e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
COPD: mechanisms and biomarker
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association of testosterone level with phenotypic characteristics and long-term outcomes of men with COPD in the ECLIPSE cohort
R. Casaburi, R. V. Clark, B. Miller, L. Edwards, S. Rennard, R. Tal-Singer, R. Swerdloff, C. Wang (Torrance, Research Triangle Park, King of Prussia, Omaha, United States Of America)
Source:
Annual Congress 2011 - COPD: mechanisms and biomarker
Session:
COPD: mechanisms and biomarker
Session type:
Oral Presentation
Number:
2931
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Casaburi, R. V. Clark, B. Miller, L. Edwards, S. Rennard, R. Tal-Singer, R. Swerdloff, C. Wang (Torrance, Research Triangle Park, King of Prussia, Omaha, United States Of America). Association of testosterone level with phenotypic characteristics and long-term outcomes of men with COPD in the ECLIPSE cohort. Eur Respir J 2011; 38: Suppl. 55, 2931
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
SGRQ-C distribution in the evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) cohort: Characteristics of COPD subjects with extreme score quintiles
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
Source: Eur Respir J 2013; 42: 636-646
Year: 2013
Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016
Gender differences in health status in patients with COPD: baseline characteristics of a multi-centre intervention and characterisation study on Seretide (COSMIC)
Source: Eur Respir J 2002; 20: Suppl. 38, 262s
Year: 2002
Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Association between patient-reported outcomes and exercise test outcomes in patients with COPD.
Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases
Year: 2020
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Health status and gender predict time to next exacerbation in patients with COPD
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
The association of comorbidity clusters with long-term survival and incidence of exacerbation in a COPD cohort. The HUNT Study, Norway.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Russian IPF Registry: time of inclusion impacts patients’ status
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Exploring the association between Socioeconomic status and asthma exacerbations: a real-world prospective cohort study in Chinese adults
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
Impact of age in the clinical expression of COPD in Greek patients
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma
Source: Eur Respir J, 50 (2) 1700019; 10.1183/13993003.00019-2017
Year: 2017
Impact of morning symptoms on 18-mo COPD outcomes across psychological distress status: a population-based study
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010
Clinical phenotypic differences between COPD and asthma in elderly patients
Source: Eur Respir J 2004; 24: Suppl. 48, 60s
Year: 2004
Longitudinal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018
LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept